🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The HIVconsv gene was constructed by assembling the 14 most conserved regio...
Status
Completed
Location
Germans Trias i Pujol Hospital
Start Date
2012-10
Trial ID
NCT01712425
Treatments Being Tested
BCN03 is a Single-site, randomized, double-blind, placebo-controlled, phase...
Status
Completed
Location
Germans Trias i Pujol Hospital
Start Date
2022-03-30
Trial ID
NCT05208125
Tuberculous paradoxical reactions (PR) are immune reactions occurring durin...
Status
Completed
Location
Georges Pompidou Hospital
Start Date
2011-03-14
Trial ID
NCT01252992
The purpose of this clinical study is to evaluate the safety and immunogeni...
Status
Recruiting
Location
Hubei Provincial Center for Disease Control and Prevention
Start Date
2025-04-04
Trial ID
NCT06932523
The purpose of this study is to evaluate immunogenicity and safety of diffe...
Status
Unknown
Location
Multiple Locations
Start Date
2023-04-01
Trial ID
NCT05457946
Treatments Being Tested
The candidate malaria vaccine RTS,S/AS02A developed by GSK Biologicals demo...
Status
Completed
Location
U.S. Army Research Unit-Kenya
Start Date
2005-07
Trial ID
NCT00197054
Treatments Being Tested
The purpose of this study is to assess the immunogenicity and safety of the...
Status
Completed
Location
Las Piñas Doctors Hospital
Start Date
2022-06-13
Trial ID
NCT05188677
Treatments Being Tested
This is a randomized, placebo-controlled, multi-site, double-blind trial of...
Status
Completed
Location
CHUM
Start Date
2017-08-01
Trial ID
NCT03031912
Treatments Being Tested
The primary objective of the study is to evaluate the pharmacokinetic (PK) ...
Status
Completed
Location
Central Kentucky Research Associates
Start Date
2013-10
Trial ID
NCT01967719
This Phase IIb clinical study aims to compare the immunogenicity and safety...
Status
Completed
Location
Hospital Germans Trias I Pujol
Start Date
2021-11-16
Trial ID
NCT05142553
Treatments Being Tested